| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Torres KA et al. | Activity of the aqueous extract of Schinus terebinthifolius Raddi on strains of the Candida genus. | 2016 | Rev Bras Ginecol Obstet | pmid:28038478 |
| Szwarc K et al. | Intramolecular transformation of an antifungal antibiotic nystatin A into its isomer, iso-nystatin A - structural and molecular modeling studies. | 2016 | Magn Reson Chem | pmid:27379602 |
| Clark RS et al. | Validation of research trajectory 1 of an Exposome framework: Exposure to benzo(a)pyrene confers enhanced susceptibility to bacterial infection. | 2016 | Environ. Res. | pmid:26765097 |
| Konecna A et al. | ERG6 gene deletion modifies Kluyveromyces lactis susceptibility to various growth inhibitors. | 2016 | Yeast | pmid:27668979 |
| Fabio CA et al. | Use of photodynamic therapy and chitosan for inactivacion of Candida albicans in a murine model. | 2016 | J. Oral Pathol. Med. | pmid:26991463 |
| Preissner S et al. | Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study. | 2016 | Mycoses | pmid:26932256 |
| Vega F et al. | Concomitant sensitization to inhaled budesonide and oral nystatin presenting as allergic contact stomatitis and systemic allergic contact dermatitis. | 2016 | Cutis | pmid:26919353 |
| Graziano S et al. | The global effect of exposing bakers' yeast to 5-fluoruracil and nystatin; a view to Toxichip. | 2016 | Chemosphere | pmid:26694798 |
| Kantarcioglu AS et al. | Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole. | 2016 | Mycopathologia | pmid:26442855 |
| Pinto Reis C et al. | Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. | 2016 | Pharm Dev Technol | pmid:25567611 |
| Ellepola AN et al. | Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates. | 2016 | J Investig Clin Dent | pmid:25388637 |
| Ellepola AN et al. | Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans. | 2015 Jul-Aug | J Appl Oral Sci | pmid:26398514 |
| Malik A et al. | Stimulation of erythrocyte cell membrane scrambling by nystatin. | 2015 | Basic Clin. Pharmacol. Toxicol. | pmid:24894380 |
| Tamura M et al. | Involvement of an intracellular vesicular transport process in naked-sgRNA-mediated TRUE gene silencing. | 2015 | Mol Med Rep | pmid:26238202 |
| Bassi P and Kaur G | Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization. | 2015 | Eur J Pharm Biopharm | pmid:26235393 |
| Cui H et al. | Functional manipulations of the tetramycin positive regulatory gene ttmRIV to enhance the production of tetramycin A and nystatin A1 in Streptomyces ahygroscopicus. | 2015 | J. Ind. Microbiol. Biotechnol. | pmid:26233316 |
| Franiczek R et al. | β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin. | 2015 | Med. Mycol. | pmid:26092104 |
| Urban VM et al. | Effect of the addition of antimicrobial agents on Shore A hardness and roughness of soft lining materials. | 2015 | J Prosthodont | pmid:25082183 |
| Sharifzadeh A et al. | Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract. | 2015 | Mycoses | pmid:26152466 |
| Al-Shayyab MH et al. | Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan. | 2015 | Int Dent J | pmid:26148537 |